Effect of COVID-19 on Serum Activity of Liver Enzymes: Is This Associated with Severity and Mortality Rate?

被引:0
|
作者
Alavian, Seyed Ehsan [1 ]
Mofidi, Mohammad [2 ]
Shahabipour, Fahimeh [3 ,4 ]
机构
[1] MELD Ctr, Middle East Liver Dis MELD Virol Lab, Tehran, Iran
[2] Golestan Univ Med Sci, Fac Paramed, Dept Lab Sci, Gorgan, Iran
[3] Mashhad Univ Med Sci, Orthoped Res Ctr, Mashhad, Iran
[4] Shahid Beheshti Med Sci, Skin Res Ctr, Tehran, Iran
关键词
COVID-19; liver enzyme; coronavirus; liver injury; mortality;
D O I
10.1055/s-0042-1759739
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Coronavirus disease 2019 (COVID-19) is a viral infection caused by a novel coronavirus known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease raises an enormous public health challenge for the international community. Liver enzymes have been reported to be frequently elevated in hospitalized patients with severe COVID-19 disease. Materials and Methods This article is a narrative review of abnormal liver tests and liver injury as a manifestation of progression to severe pneumonia. We collected data from the PubMed database (National Library of Medicine, Bethesda, Maryland, United States). We used the search term "abnormal liver test " and relevant records were measured. The review article was organized thematically. Results This narrative review aims to summarize the available clinical data on abnormal liver enzymes in coronavirus infection and its association with the risk of mortality, severer pneumonia, and systemic inflammation. Some clinical studies refer to abnormal liver tests and liver injury as a manifestation of progression to severe pneumonia. Recent research verified the relationship between hepatic liver enzyme activities and liver damage in patients with COVID-19, which suggested that it might reflect the infection severity and the mortality risk. Thus, this review investigated the correlation between liver serum enzymes level and the severity of COVID-19 patients, by reviewing investigating the relationship between the illness severity in COVID-19 patients with abnormal liver tests, liver pathology, and markers of inflammation. Conclusion In the current pandemic of SARS-CoV-2, abnormalities of liver enzyme tests were commonly observed in patients with COVID-19. However, because of multiorgan damages that observed in COVID-19 patients, various issues should be considered such as the pathology and pathophysiology of the liver tissue, especially on the activation process of the immune response and cytokine storm to prevent the severity of the disease.
引用
收藏
页码:86 / 93
页数:8
相关论文
共 50 条
  • [1] Serum Activity of Liver Enzymes Is Associated With Higher Mortality in COVID-19: A Systematic Review and Meta-Analysis
    Boregowda, Umesha
    Aloysius, Mark M.
    Perisetti, Abhilash
    Gajendran, Mahesh
    Bansal, Pardeep
    Goyal, Hemant
    [J]. FRONTIERS IN MEDICINE, 2020, 7
  • [2] Serum cholinesterase associated with COVID-19 pneumonia severity and mortality
    Nakajima, Kento
    Abe, Takeru
    Saji, Ryo
    Ogawa, Fumihiro
    Taniguchi, Hayato
    Yamaguchi, Keishi
    Sakai, Kazuya
    Nakagawa, Tomoki
    Matsumura, Reo
    Oi, Yasufumi
    Nishii, Mototsugu
    Takeuchi, Ichiro
    [J]. JOURNAL OF INFECTION, 2021, 82 (02) : 321 - 323
  • [3] Serum Testosterone Is Associated With the Severity of COVID-19
    Suzuki, Ema
    Kuronuma, Koji
    Murai, Ryosei
    Fujiya, Yoshihiro
    Saito, Atsushi
    Chiba, Hirofumi
    Takahashi, Satoshi
    [J]. IN VIVO, 2023, 37 (05): : 2314 - 2319
  • [4] Laboratory Biomarkers Associated with Severity and Mortality of COVID-19
    Allarakia, Basmah M. Azad
    Gattan, Hattan
    Al-Ahmadi, Bassam M.
    Abdeen, Rawan H.
    Bazaid, Mohammed B.
    Shater, Abdullah F.
    Jalal, Mohammed M.
    Saeedi, Nizar H.
    Mohammedsaleh, Zuhair M.
    Altayar, Malik A.
    Alreshidi, Maha
    Bazaid, Abdulrahman S.
    [J]. CLINICAL LABORATORY, 2021,
  • [5] Laboratory Biomarkers Associated with Severity and Mortality of COVID-19
    Allarakia, Basmah M. Azad
    Gattan, Hattan
    Al-Ahmadi, Bassam M.
    Abdeen, Rawan H.
    Bazaid, Mohammed B.
    Shater, Abdullah F.
    Jalal, Mohammed M.
    Saeedi, Nizar H.
    Mohammedsaleh, Zuhair M.
    Altayar, Malik A.
    Alreshidi, Maha
    Bazaid, Abdulrahman S.
    [J]. CLINICAL LABORATORY, 2022, 68 (02) : 291 - 297
  • [6] Biomarker Profiles Associated with COVID-19 Severity and Mortality
    Sanchez-Diez, Silvia
    Gomez-Olles, Carlos
    Cruz, Maria-Jesus
    de Homdedeu, Miquel
    Espejo, David
    Ferrer, Jaume
    Roca, Oriol
    Pacheco, Andres
    Munoz, Xavier
    [J]. CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (03) : 1998 - 2012
  • [7] Biomarker profiles associated with COVID-19 severity and mortality
    Sanchez-Diez, S.
    Gomez Olles, C.
    De Homdedeu, M.
    Espejo, D.
    Fabregas, C.
    Cruz, M. J.
    Munoz, X.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [8] Memory B cells and serum immunoglobulins are associated with disease severity and mortality in patients with COVID-19
    Colkesen, Fatih
    Kepenek Kurt, Esma
    Vatansev, Hulya
    Korkmaz, Celalettin
    Colkesen, Fatma
    Yucel, Fatih
    Yildiz, Eray
    Evcen, Recep
    Aykan, Filiz Sadi
    Kilinc, Mehmet
    Aytekin, Gokhan
    Feyzioglu, Bahadir
    Dogan, Metin
    Arslan, Sevket
    Teke, Turgut
    Keles, Sevgi
    Reisli, Ismail
    [J]. POSTGRADUATE MEDICAL JOURNAL, 2022, 98 (1164) : 765 - 771
  • [9] A risk index for COVID-19 severity is associated with COVID-19 mortality in New York City
    Wil Lieberman-Cribbin
    Naomi Alpert
    Raja Flores
    Emanuela Taioli
    [J]. BMC Public Health, 21
  • [10] A risk index for COVID-19 severity is associated with COVID-19 mortality in New York City
    Lieberman-Cribbin, Wil
    Alpert, Naomi
    Flores, Raja
    Taioli, Emanuela
    [J]. BMC PUBLIC HEALTH, 2021, 21 (01)